U.S. Stock Futures Mixed, Heads for a Winning Week
U.S. stock futures were mixed as the S&P 500 headed for a winning week after a new all-time high. Retail sales fell 0.6% in July, though were up 5% year over year, per the Commerce Department. Earnings: AMAT adjusted EPS $3.50 (vs $3.38 est) on $9.12B revenue; NKTR adjusted loss $1.23 (vs $2.06 est) on $10.13M revenue; STNE adjusted EPS $0.47 (vs $0.46 est) on $709.9M revenue.
How this was made

The 30-second read
Why it matters
Retail sales decreased month-over-month but rose year-over-year, while the earnings section shows one clear beat (AMAT) and mixed results for NKTR and STNE. The macro preview adds near-term volatility risk around consumer sentiment and inventories.
Market read
Traders get three company-specific earnings datapoints plus a schedule of after-hours and upcoming macro releases that can move index futures and sector sentiment.
What to watch
The article omits forward guidance, margins, and pipeline or customer metrics, which are often the real drivers of post-earnings repricing.
Background
The piece is a market wrap that also summarizes three companies’ quarterly earnings and previews upcoming US consumer sentiment and business inventories data.
Ticker impact
Applied Materials reported quarterly adjusted EPS of $3.5, beating the $3.38 Zacks consensus, and revenue of $9.12B beat estimates.
Likely supportive for AMAT over the next few sessions, with follow-through dependent on guidance not provided here.
The article provides a clear beat versus consensus for both EPS and revenue, but includes no forward guidance or margin detail to gauge durability.
Nektar Therapeutics posted a narrower adjusted loss of $1.23 per share versus a $2.06 consensus, but revenue missed.
Near-term reaction could be mixed, with downside risk if revenue weakness dominates.
The text highlights both an EPS improvement versus consensus and a revenue miss, without additional drivers like pipeline updates or guidance.
StoneCo reported adjusted EPS of $0.47, beating the $0.46 consensus, while revenue of $709.88M missed by 2.91%.
Likely range-bound to mildly positive, but revenue miss could cap upside.
The article gives a modest EPS beat and a clear revenue miss, with no guidance or operational commentary to resolve the trade-off.
Market effects
Semiconductor equipment (AMAT) earnings beat can support broader semicap sentiment; biotech (NKTR) and fintech/cloud (STNE) are mixed signals for risk appetite.
Primarily US-focused via retail sales and consumer sentiment expectations; company earnings are company-specific.
Limited direct global spillover beyond semicap sentiment and general risk-on positioning.
Counterpoint
EPS beats may not translate into sustained upside if revenue misses or lack of guidance indicate underlying demand or cost pressures.
Key entities
- companyApplied Materials
Reported adjusted EPS and revenue results versus Zacks consensus.
- companyNektar Therapeutics
Reported narrower adjusted loss but missed revenue versus consensus.
- companyStoneCo
Reported a small EPS beat but missed revenue versus consensus.
- institutionUniversity of Michigan
Will report preliminary Consumer Sentiment Index for August after the close.
- government agencyU.S. Census Bureau
Will announce Business Inventories and Sales data for June.

